Patent directory · USPTO A61K / A61P
Patents matching “therapy”
782 pharma patents match "therapy" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 782 pharmaceutical patents matching "therapy" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11452775
Detection of arginine methylation of EGFR for prediction of resistance to therapy
granted -
US 11453719
Compositions and methods for treating cancer with anti-ROR1 immunotherapy
granted -
US 11453640
Small molecules for disrupting the super elongation complex and inhibiting transcription elongation for cancer therapy
granted -
US 11452709
Compositions and methods for preventing and treating radiation-induced bystander effects caused by radiation or radiotherapy
granted -
US 11446332
Combinatorial cancer immunotherapy
granted -
US 11446397
Gene therapy vectors for treating heart disease
granted -
US 11439683
Anti-angiogenic therapy of metastatic colorectal cancer
granted -
US 11439632
Use of neuronal nitric oxide synthase inhibitors for immunotherapy in melanoma patients
granted -
US 11433131
Adoptive cell therapy using spherical nucleic acids (SNAs)
granted -
US 11433143
Nano-enabled immunotherapy in cancer
granted -
US 11427646
Antibodies against carcinoembryonic antigen for cancer therapy and diagnosis
granted -
US 11426385
Methods of improving cancer chemotherapy
granted -
US 11421034
Combination anti-CSF1R and anti-PD-1 antibody combination therapy for pancreatic cancer
granted -
US 11419898
Combinatorial cancer immunotherapy
granted -
US 11414489
Combination therapy with a hyaluronan-degrading enzyme and an immune checkpoint inhibitor
granted -
US 11401506
Enhanced expansion of tumor-infiltrating lymphocytes for adoptive cell therapy
granted -
US 11397184
Selection of patients for combination therapy
granted -
US 11395838
Methods for enhancing immune checkpoint blockade therapy by modulating the microbiome
granted -
US 11396647
Human methylthioadenosine/adenosine depleting enzyme variants for cancer therapy
granted -
US 11389480
Human monoclonal antibody targeting TNFR2 for cancer immunotherapy
granted -
US 11389432
Methods of treating cancer comprising administration of a glucocorticoid receptor modulator and a cancer chemotherapy agent
granted -
US 11389481
Allogeneic cell therapy of B cell malignancies using genetically engineered T cells targeting CD19
granted -
US 11384337
Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy
granted -
US 11376324
Sting activating nanovaccine for immunotherapy
granted